All News about Teva Pharmaceutical Industries ADR
Analyst Ratings for Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
![]() Via Benzinga
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
November 23, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]()
Teva Finalizes Nationwide Opioid Settlement Terms
November 22, 2022
Via Business Wire
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]()
Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M
November 10, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]()
Teva Reports Third Quarter 2022 Financial Results
November 03, 2022
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|